相似文献
1
Gene therapy for hemophilia: the clot thickens.
Hum Gene Ther. 2014 Nov;25(11):915-22. doi: 10.1089/hum.2014.2541.
2
Status of gene transfer for hemophilia A and B.
Thromb Haemost. 1991 Jul 12;66(1):119-22.
3
A golden age for Haemophilia treatment?
Haemophilia. 2018 Mar;24(2):175-176. doi: 10.1111/hae.13411.
4
Genie in a vector.
Sci Am. 2015 Jan;312(1):S6-7. doi: 10.1038/scientificamerican0115-s6.
5
Molecular basis of hemophilia.
Hematol Pathol. 1990;4(1):1-26.
6
Looking to the future of gene therapy for hemophilia A and B.
Expert Rev Hematol. 2023 Jul-Dec;16(11):807-809. doi: 10.1080/17474086.2023.2268279. Epub 2023 Nov 17.
7
Gene therapy for haemophilia.
Baillieres Clin Haematol. 1996 Jun;9(2):305-17. doi: 10.1016/s0950-3536(96)80065-5.
8
Deficiencies in factors IX and VIII: what is now known.
Hosp Pract (Off Ed). 1992 Feb 15;27(2):41-51. doi: 10.1080/21548331.1992.11705358.
9
Molecular biology of the hemophilias.
Prog Hemost Thromb. 1991;10:175-214.
10
First hemophilia B gene therapy approved: More than two decades in the making.
Mol Ther. 2023 Jan 4;31(1):1-2. doi: 10.1016/j.ymthe.2022.12.001. Epub 2022 Dec 16.
引用本文的文献
1
Congenital Bleeding Disorders: Managing Central Nervous System Bleeding in an Adult Hemophiliac.
Cureus. 2023 Mar 30;15(3):e36906. doi: 10.7759/cureus.36906. eCollection 2023 Mar.
2
Comparison of different gene addition strategies to modify placental derived-mesenchymal stromal cells to produce FVIII.
Front Immunol. 2022 Dec 15;13:954984. doi: 10.3389/fimmu.2022.954984. eCollection 2022.
3
Organoids and microphysiological systems: Promising models for accelerating AAV gene therapy studies.
Front Immunol. 2022 Sep 26;13:1011143. doi: 10.3389/fimmu.2022.1011143. eCollection 2022.
4
Dexamethasone Transiently Enhances Transgene Expression in the Liver When Administered at Late-Phase Post Long-Term Adeno-Associated Virus Transduction.
Hum Gene Ther. 2022 Feb;33(3-4):119-130. doi: 10.1089/hum.2021.083. Epub 2022 Jan 6.
5
Defining the Optimal FVIII Transgene for Placental Cell-Based Gene Therapy to Treat Hemophilia A.
Mol Ther Methods Clin Dev. 2020 Mar 14;17:465-477. doi: 10.1016/j.omtm.2020.03.001. eCollection 2020 Jun 12.
6
CRISPR/Cas9-mediated knockin of human factor IX into swine factor IX locus effectively alleviates bleeding in hemophilia B pigs.
Haematologica. 2021 Mar 1;106(3):829-837. doi: 10.3324/haematol.2019.224063.
7
Clinical Considerations for Capsid Choice in the Development of Liver-Targeted AAV-Based Gene Transfer.
Mol Ther Methods Clin Dev. 2019 Sep 10;15:170-178. doi: 10.1016/j.omtm.2019.08.015. eCollection 2019 Dec 13.
8
Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors.
Mol Ther Methods Clin Dev. 2016 Dec 24;4:149-158. doi: 10.1016/j.omtm.2016.12.004. eCollection 2017 Mar 17.
9
Clinical and imaging analysis of subclinical hemophilia combined with coxarthrosis: case report and literature review.
Springerplus. 2016 Dec 1;5(1):2058. doi: 10.1186/s40064-016-3727-7. eCollection 2016.
本文引用的文献
1
Immune responses to AAV vectors: overcoming barriers to successful gene therapy.
Blood. 2013 Jul 4;122(1):23-36. doi: 10.1182/blood-2013-01-306647. Epub 2013 Apr 17.
2
The gene therapy journey for hemophilia: are we there yet?
Blood. 2012 Nov 29;120(23):4482-7. doi: 10.1182/blood-2012-05-423210. Epub 2012 Jul 24.
3
Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer.
Blood. 2012 Mar 29;119(13):3038-41. doi: 10.1182/blood-2011-09-382317. Epub 2012 Jan 23.
4
Adenovirus-associated virus vector-mediated gene transfer in hemophilia B.
N Engl J Med. 2011 Dec 22;365(25):2357-65. doi: 10.1056/NEJMoa1108046. Epub 2011 Dec 10.
5
Cell phones and landlines: the impact of gene therapy on the cost and availability of treatment for hemophilia.
Mol Ther. 2011 Oct;19(10):1749-50. doi: 10.1038/mt.2011.203.
6
Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges.
Nat Rev Genet. 2011 May;12(5):341-55. doi: 10.1038/nrg2988.
7
X-linked thrombophilia with a mutant factor IX (factor IX Padua).
N Engl J Med. 2009 Oct 22;361(17):1671-5. doi: 10.1056/NEJMoa0904377.
8
Genotype analysis identifies the cause of the "royal disease".
Science. 2009 Nov 6;326(5954):817. doi: 10.1126/science.1180660. Epub 2009 Oct 8.
9
Gene therapy for haemophilia.
Br J Haematol. 2008 Mar;140(5):479-87. doi: 10.1111/j.1365-2141.2007.06942.x.
10
Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivo.
J Virol. 2007 Jul;81(14):7540-7. doi: 10.1128/JVI.00529-07. Epub 2007 May 2.
Zotero 插件